Skip to main content

Table 4 Characteristics of non-AGI and AGI patients

From: Predictive value of transabdominal intestinal sonography in critically ill patients: a prospective observational study

 

Total (n = 116)

Non-AGI (n = 80)

AGI (n = 36)

t/Z/χ

p value

Age (year)

53.4 ± 20.6

53.9 ± 21.6

52.2 ± 18.5

0.41a

0.68

Male/female, n (%)

62/54

42/38

20/16

0.09c

0.76

BMI (kg/m2)

22.3 ± 3.9

22.1 ± 3.9

22.5 ± 4.0

0.49a

0.63

Cause of ICU admission

 Major trauma, n (%)

59 (50.9)

43 (53.8)

16 (44.4)

0.86c

0.35

 Complications after surgery, n (%)

45 (38.8)

30 (37.5)

15 (41.7)

0.18c

0.67

 Others, n (%)

12 (10.3)

7 (8.8)

5 (13.9)

0.71c

0.40

Serum lactate at onset (mmol/L)

2.4 ± 1.0

2.3 ± 1.0

2.5 ± 0.9

1.21a

0.23

APACHE II on ICU admission

15.0 [11.0–17.0]

15.0 [11.0–17.0]

14.5 [13.0–18.0]

1.83b

0.78

SOFA score on ICU admission

10.0 [8.0–13.0]

9.5 [8.0–13.0]

10.0 [9.3–13.0]

5.14b

0.48

Mechanical ventilation, n (%)

62 (53.5)

36 (45.0)

26 (72.2)

7.40c

0.007

PaO2/FiO2 (mmHg)

206.5 ± 21.5

209.8 ± 20.7

199.1 ± 21.6

2.54a

0.01

Platelet count (× 109/L)

133.7 ± 19.7

137.11 ± 19.7

126.11 ± 17.7

2.87a

0.005

Total bilirubin (mmol/L)

70.1 ± 32.8

54.1 ± 22.7

105.8 ± 22.0

11.46a

< 0.001

MAP (mmHg)

75.0 ± 6.2

75.2 ± 5.6

74.3 ± 7.4

0.76a

0.45

Vasopressor support, n (%)

59 (50.9)

35 (43.8)

24 (66.7)

5.22c

0.02

 Norepinephrine, n (%)

59 (50.9)

35 (43.8)

24 (66.7)

5.22c

0.02

 Epinephrine, n (%)

7 (6.0)

2 (2.5)

5 (13.9)

5.68c

0.02

 Dobutamine, n (%)

3 (2.6)

0 (0)

3 (8.3)

6.84c

0.009

 Norepinephrine dose (μg/kg/min)

0.06 [0.03–0.15]

0.04 [0.03–0.06]

0.15 [0.09–0.24]

5.22b

< 0.001

 At least two drugs, n (%)

9 (7.8)

2 (2.5)

7 (19.4)

9.96c

0.002

Serum creatinine (μmol/L)

94.0 [61.5–131.8]

80.0 [50.5–107.3]

162.0 [108.5–200.8]

18.64b

< 0.001

Renal replacement therapy, n (%)

34 (29.3)

19 (23.8)

15 (41.7)

3.85c

0.05

Intra-abdominal pressure (mmHg)

10.6 ± 6.3

8.4 ± 5.5

15.5 ± 5.3

6.57a

< 0.001

Abdominal perfusion pressure (mmHg)

64.3 ± 8.3

66.9 ± 7.8

58.8 ± 6.6

5.41a

< 0.001

Intra-abdominal hypertension, n (%)

78 (67.2)

43 (53.8)

35 (97.2)

21.30c

< 0.001

Feeding intolerance, n (%)

41 (35.3)

5 (6.3)

36 (100)

95.49c

< 0.001

Duration of mechanical ventilation (days)

3.0 [0.0–12.8]

1.0 [0–7.0]

12.0 [0–14.8]

4.48b

< 0.001

AGIUS score

2.0 [1.0–3.0]

2.0 [1.0–3.0]

4.0 [3.0–4.0]

5.85b

< 0.001

GUTS score

3.0 [2.0–3.0]

3.0 [2.0–3.0]

3.0 [3.0–3.0]

4.60b

< 0.001

Length of ICU stay (days)

9.5 [6.0–18.0]

8.0 [5.0–14.5]

17.0 [8.8–21.0]

3.38b

0.001

Length of hospital stay (days)

17.0 [11.0–23]

14.0 [10.0–20.8]

21.0 [19.0–25.8]

3.75b

< 0.001

28-day mortality, n (%)

42 (36.2)

14 (17.5)

28 (77.8)

39.06c

< 0.001

ICU mortality, n (%)

37 (31.9)

12 (15.0)

25 (69.4)

38.21c

< 0.001

Hospital mortality, n (%)

41 (35.3)

14 (17.5)

27 (75)

35.92c

< 0.001

  1. Variables including PaO2/FiO2, platelet count, total bilirubin, norepinephrine dose, serum creatinine, and duration of mechanical ventilation were reported as the average values during stay in the ICU. Variables including mechanical ventilation, vasopressor support, and renal replacement therapy were reported as the number of patients receiving these treatments during stay in the ICU. Variables including MAP, intra-abdominal pressure, and abdominal perfusion pressure were reported as the average values of the first week after ICU admission. Variables including AGIUS score and GUTS score were reported as the highest values recorded during the first week after ICU admission. Variables including intra-abdominal hypertension and feeding intolerance were reported as the number of patients of the first week after ICU admission
  2. p value represents the difference between non-AGI patients and AGI patients
  3. Continuous data are expressed as median [Q1; Q3] or mean ± standard
  4. BMI body mass index
  5. aStudent’s t test
  6. bMann-Whitney Utest
  7. cχ2 test or Fisher’s exact test